Results from PEARL study (GEICAM/2013-02_CECOG/BC.1.3.006): A phase 3 trial of Palbociclib (PAL) in combination with endocrine therapy (ET) versus Capecitabine (CAPE) in hormonal receptor (HR)-positive/human epidermal growth factor receptor (HER) 2-negative metastatic breast cancer (MBC) patients (pts) whose disease progressed on aromatase inhibitors (AIs)

Por: Martin, M, Zielinski, C, Ruiz-Borrego, M, Carrasco, E, Ciruelos, E, Munoz, M, Bermejo, B, Margeli, M, Turner, N, Casas, M, Anton, A, Csoszi, T, Corsaro, M, Murillo, L, Morales, S, Alba, E, Bartlett, CH, Koehler, M, Guerrero, A, Kahan, Z and Gil-Gil, M

---

Publicada: 1 feb 2020

---

---

Filiaciones:
Martin, M:
 ISCIII, CIBERONC, Inst Invest Sanitaria Gregorio Maranon, GEICAM Spanish Breast Canc Grp, Madrid, Spain

Zielinski, C:
 Med Univ Vienna, Vienna Canc Ctr, Vienna, Austria

 Vienna Hosp Assoc, Cent European Cooperat Oncol Grp CECOG, Vienna, Austria

Ruiz-Borrego, M:
 Hosp Univ Virgen del Rocio, GEICAM Spanish Breast Canc Grp, Seville, Spain

Carrasco, E:
 GEICAM Spanish Breast Canc Grp, Madrid, Spain

Ciruelos, E:
 Hosp Univ 12 Octubre, GEICAM Spanish Breast Canc Grp, Madrid, Spain

Munoz, M:
 Hosp Univ Clin Barcelona, Spanish Breast Canc Grp, Barcelona, Spain

Bermejo, B:
 ISCIII, CIBERONC, INCLIVA Valencia, Clin Univ Valencia,GEICAM Spanish Breast Canc Grp, Valencia, Spain

:
 Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, ARGO Grp, GEICAM Spanish Breast Canc Grp, Barcelona, Spain

Turner, N:
 Inst Canc Res, London, England

 Royal Marsden, London, England

Casas, M:
 GEICAM Spanish Breast Canc Grp, Madrid, Spain

Anton, A:
 Hosp Univ Miguel Servet, GEICAM Spanish Breast Canc Grp, Zaragoza, Spain

Csoszi, T:
 Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz R, Szolnok, Hungary

Corsaro, M:
 Pfizer Inc, Milan, Italy

Murillo, L:
 Hosp Clin Zaragoza Lozano Blesa, GEICAM Spanish Breast Canc Grp, Zaragoza, Spain

Morales, S:
 Hosp Arnau Vilanova, GEICAM Spanish Breast Canc Grp, Lleida, Spain

Alba, E:
 Hosp Clin Univ Virgen de la Victoria, Malaga, ES, Spain

 ISCIII, CIBERONC, 18Inst Invest Biomed Malaga, IBIMA,GEICAM Spanish Breast Canc Grp, Malaga, Spain

Bartlett, CH:
 Pfizer Inc, New York, NY USA

Koehler, M:
 Repare Therapeut, Cambridge, MA USA

Guerrero, A:
 Inst Valenciano Oncol, GEICAM Spanish Breast Canc Grp, Valencia, Spain

Kahan, Z:
 Univ Szeged, Dept Oncotherapy, Szeged, Hungary

Gil-Gil, M:
 ICO, GEICAM Spanish Breast Canc Grp, Barcelona, Spain